COMMUNIQUÉS West-GlobeNewswire

Doheny Eye Institute Announces Upcoming Presentations at the American Academy of Ophthalmology 2025 Annual Meeting
09/10/2025
Doheny-UCLA clinician-scientists selected to deliver more than 25 presentations and talks PASADENA, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research [...]
Safety Shot, Inc. to Become Bonk, Inc., to Trade on Nasdaq Under New Ticker Symbol “BNKK”
09/10/2025
Rebranding Solidifies Company’s Full Strategic Transformation into the Premier Public Vehicle for the BONK Ecosystem SCOTTSDALE, AZ, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company”) [...]
Children's National Hospital receives $8 million grant from Gilbert Family Foundation to advance neurofibromatosis research
09/10/2025
The investment deepens a partnership to transform care for one of the most common genetic conditions in children Washington, DC, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Children’s National Hospital and the Gilbert Family [...]
Legend Senior Living® Grows Florida Footprint With Renaissance of North Tampa
09/10/2025
WICHITA, Kan., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living®, a nationally recognized senior living provider based in Wichita, KS, has announced the management of Renaissance North Tampa, expanding its Florida [...]
Foundation Health Secures $20M Series A to Scale AI-Powered Infrastructure for Pharmacy Operations, Care Coordination, and Direct-to-Patient Delivery
09/10/2025
Funding Supports Expansion of PAIGE AI Pharmacist Assistant, Driving Intelligent Automation for Prior Authorizations and Patient Communication Comprehensive Platform Reduces Manual Pharmacy Workflows by Up to 75% While [...]
Triumph Steps Launches CLE-Eligible Mental Fitness Program for Lawyers
09/10/2025
Program Aligns with World Mental Health Day, Offering Attorneys a Path to Wellness, Ethics, and Emotional Resilience Miami, Florida, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Triumph Steps , a leading provider of emotional [...]
Optime Care Terminates Distributor Agreement for Korlym® (mifepristone)
09/10/2025
ST. LOUIS, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Following 10+ years of service to Cushing's syndrome patients, Optime Care , a national specialty pharmacy, distribution and patient management organization maximizing [...]
Toro Neurovascular and Kaneka Announce Exclusive U.S. Distribution Partnership
09/10/2025
Partnership to Enable U.S. Access to Toro’s Novel Neurovascular Catheter Portfolio Pending Regulatory Approval IRVINE, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Toro Neurovascular, a company pioneering advanced catheter [...]
Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer
09/10/2025
Pioneering Evidence-Based AI Innovation in Personalized Wellness and Health Research VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY [...]
Applications Now Open for Fall 2025 First Practice Fund Scholarship
09/10/2025
ST. LOUIS and HINTON, West Virginia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- PracticeLink , the nation’s most trusted physician recruitment resource and home of the most widely used online physician job board, is proud to [...]
Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando
09/10/2025
Results from the study of oral gildeuretinol in moderate Stargardt disease to be presented as late-breaker during Retina Subspecialty Day CAMBRIDGE, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc [...]
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
09/10/2025
Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse models CAMBRIDGE, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT [...]
Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer
09/10/2025
VANCOUVER, British Columbia, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the [...]
Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial
09/10/2025
STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
Novo Nordisk to acquire Akero Therapeutics and its promising phase 3 FGF21 analogue to expand MASH portfolio
09/10/2025
Acquisition adds potential first- and best-in-class asset, enhancing Novo Nordisk’s portfolio for treatment of MASH, one of the most prevalent obesity related comorbidities Akero Therapeutics’s FGF21 analogue [...]
Human Appeal's Pot of Gold Film to Air on EarthX Channel on October 18
09/10/2025
BayView Entertainment to Bring Groundbreaking Documentary to Streaming and Broadcast Audiences MISSION VIEJO, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Pot of Gold , a powerful independent documentary set in the [...]
Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion
09/10/2025
Shareholders to Receive $54 Per Share in Cash and CVR of $6 Per Share Advances Akero’s Mission of Bringing Novel Therapies to Patients with High Unmet Medical Needs SOUTH SAN FRANCISCO, Calif., Oct. 09, 2025 (GLOBE [...]
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast tablets) as first new treatment option for adults with IPF in over a decade
09/10/2025
Ingelheim, Germany/Ridgefield, Connecticut, U.S. Idiopathic pulmonary fibrosis (IPF) is a progressive disease, causing a continuous decline in lung function. 1 Approval is based on results from two clinical trials, [...]
Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform
09/10/2025
ACTON, Mass. and YAMANASHI, Japan, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”), a medical diagnostics company focused on developing rapid near-patient testing solutions for [...]

Pages